Tamoxifen and the Risk of Ovarian Cancer in BRCA1 Mutation Carriers

OBJECTIVE: BRCA1 mutation carriers have a high rate of both breast and ovarian cancer. Tamoxifen is a selective estrogen receptor modulator (SERM), which is used for the treatment of primary breast cancer and for the prevention of contralateral breast cancer. Our objective is to assess if tamoxifen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vicus, Danielle, Rosen, Barry, Lubinski, Jan, Domchek, Susan, Kauff, Noah D., Lynch, Henry T., Isaacs, Claudine, Tung, Nadine, Sun, Ping, Narod, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3756313/
https://ncbi.nlm.nih.gov/pubmed/19577280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.06.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados